Skip to Content
Merck

GF93209328

Iron

tube, 200mm, outside diameter 8.0mm, inside diameter 5mm, wall thickness 1.5mm, annealed, 99.5%

Synonym(s):

Iron, FE007570

Sign In to View Organizational & Contract Pricing

Select a Size

Pricing and availability is not currently available.

About This Item

Linear Formula:
Fe
CAS Number:
Molecular Weight:
55.85
MDL number:
UNSPSC Code:
12141721
PubChem Substance ID:
NACRES:
NA.23

Skip To

Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Assay

≥99.5%

form

tubes

manufacturer/tradename

Goodfellow 932-093-28

resistivity

9.71 μΩ-cm

bp

2750 °C (lit.)

mp

1535 °C (lit.)

density

7.86 g/mL at 25 °C (lit.)

SMILES string

[Fe]

InChI

1S/Fe

InChI key

XEEYBQQBJWHFJM-UHFFFAOYSA-N

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
GF30656077GF28189525GF38919279
Iron tube, 200mm, outside diameter 8.0mm, inside diameter 5mm, wall thickness 1.5mm, annealed, 99.5%

GF93209328

Iron

Iron tube, 200mm, outside diameter 10.0mm, inside diameter 7mm, wall thickness 1.5mm, annealed, 99.5%

GF30656077

Iron

Iron tube, 200mm, outside diameter 12.7mm, inside diameter 9.5mm, wall thickness 1.6mm, annealed, 99.5%

GF28189525

Iron

Iron tube, 200mm, outside diameter 20.0mm, inside diameter 16mm, wall thickness 2.0mm, annealed, 99.5%

GF38919279

Iron

manufacturer/tradename

Goodfellow 932-093-28

manufacturer/tradename

Goodfellow 306-560-77

manufacturer/tradename

Goodfellow 281-895-25

manufacturer/tradename

Goodfellow 389-192-79

form

tubes

form

tubes

form

tubes

form

tubes

assay

≥99.5%

assay

99.50%

assay

99.50%

assay

99.5%

density

7.86 g/mL at 25 °C (lit.)

density

7.86 g/mL at 25 °C (lit.)

density

7.86 g/mL at 25 °C (lit.)

density

7.86 g/mL at 25 °C (lit.)

mp

1535 °C (lit.)

mp

1535 °C (lit.)

mp

1535 °C (lit.)

mp

1535 °C (lit.)

resistivity

9.71 μΩ-cm

resistivity

9.71 μΩ-cm

resistivity

9.71 μΩ-cm

resistivity

9.71 μΩ-cm

General description

For updated SDS information please visit www.goodfellow.com.

Legal Information

Product of Goodfellow

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Catherine F M Bowden et al.
Biochemistry, 53(14), 2286-2294 (2014-03-22)
The Isd (iron-regulated surface determinant) system is a multiprotein transporter that allows bacterium Staphylococcus aureus to take up iron from hemoglobin (Hb) during human infection. In this system, IsdB is a cell wall-anchored surface protein that contains two near iron
Maria Wilhelm et al.
Clinical nephrology, 81(4), 251-258 (2014-03-25)
Hyperphosphatemia in advanced chronic kidney disease (CKD) necessitates the use of phosphate binders. This in vitro study assessed phosphate binding and Fe release properties of the novel iron-based phosphate binder PA21. Phosphate adsorption and Fe release were assessed under conditions
Florence Lima et al.
Environmental and molecular mutagenesis, 55(3), 266-277 (2014-04-12)
DNA methylation is an epigenetic mechanism that drives phenotype and that can be altered by environmental exposures including radiation. The majority of human radiation exposures occur in a relatively low dose range; however, the biological response to low dose radiation
Antonino Missineo et al.
Infection and immunity, 82(6), 2448-2459 (2014-04-02)
Staphylococcus lugdunensis is a coagulase-negative staphylococcus that is a commensal of humans and an opportunistic pathogen. It can cause a spectrum of infections, including those that are associated with the ability to form biofilm, such as occurs with endocarditis or
S J Ford et al.
Annals of the Royal College of Surgeons of England, 96(4), 275-278 (2014-05-02)
The incidence of oesophageal adenocarcinoma (OAC) is rising dramatically and overall survival remains extremely poor. Iron has been shown to potentiate tumourigenesis in OAC, and iron chelation therapy demonstrates promise in vivo as an adjunct to neoadjuvant and palliative chemotherapy.

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service